| 臺大學術典藏 |
2020-12-18T08:37:16Z |
Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan
|
Lee C.-M.;Lai C.-C.;Chiang H.-T.;Lu M.-C.;Wang L.-F.;Tsai T.-L.;Kang M.-Y.;Jan Y.-N.;Lo Y.-T.;Ko W.-C.;Tseng S.-H.;Po-Ren Hsueh; Lee C.-M.; Lai C.-C.; Chiang H.-T.; Lu M.-C.; Wang L.-F.; Tsai T.-L.; Kang M.-Y.; Jan Y.-N.; Lo Y.-T.; Ko W.-C.; Tseng S.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:16Z |
Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295] (S0732889314004076)(10.1016/j.diagmicrobio.2014.09.027)
|
Wu J.-J.; Ko W.-C.; Jean S.-S.; Lee W.-S.; Bai K.-J.; Yu K.-W.; Hsu C.-W.; Liao C.-H.; Chang F.-Y.; Jean S.-S.;Lee W.-S.;Bai K.-J.;Yu K.-W.;Hsu C.-W.;Liao C.-H.;Chang F.-Y.;Ko W.-C.;Wu J.-J.;Chen Y.-H.;Chen Y.-S.;Liu J.-W.;Lu M.-C.;Liu C.-Y.;Chen R.-J.;Po-Ren Hsueh; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Liu C.-Y.; Chen R.-J.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:15Z |
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
|
Li M.-C.; PO-REN HSUEH; Lee N.-Y.; Ko W.-C.; Li C.-W.; Lee C.-C.; Lo C.-L.;Lee C.-C.;Li C.-W.;Li M.-C.;Po-Ren Hsueh;Lee N.-Y.;Ko W.-C.; Lo C.-L. |
| 臺大學術典藏 |
2020-12-18T08:37:14Z |
Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan
|
Hung C.-T.; Chiang H.-T.; Lai C.-C.; Lee C.-M.; Lai C.-C.;Lee C.-M.;Chiang H.-T.;Hung C.-T.;Chen Y.-C.;Su L.-H.;Shi Z.-Y.;Liu J.-W.;Liu C.-P.;Lu M.-C.;Chuang Y.-C.;Ko W.-C.;Tseng S.-H.;Chen Y.-H.;Po-Ren Hsueh;For The, Infection Control Society Of Taiwan; Chen Y.-C.; Su L.-H.; Shi Z.-Y.; Liu J.-W.; Liu C.-P.; Lu M.-C.; Chuang Y.-C.; Ko W.-C.; Tseng S.-H.; Chen Y.-H.; PO-REN HSUEH; for the, Infection Control Society of Taiwan |
| 臺大學術典藏 |
2020-12-18T08:37:12Z |
Role of rifampin for the treatment of bacterial infections other than mycobacteriosis
|
Lee C.-Y.;Huang C.-H.;Lu P.-L.;Ko W.-C.;Chen Y.-H.;Po-Ren Hsueh; Lee C.-Y.; Huang C.-H.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
Nationwide surveillance of ribotypes and antimicrobial susceptibilities of toxigenic clostridium difficile isolates with an emphasis on reduced doxycycline and tigecycline susceptibilities among ribotype 078 lineage isolates in Taiwan
|
Ko W.-C.; Hung Y.-P.;Tsai P.-J.;Lee Y.-T.;Tang H.-J.;Lin H.-J.;Liu H.-C.;Lee J.-C.;Tsai B.-Y.;Po-Ren Hsueh;Ko W.-C.; Hung Y.-P.; Tsai P.-J.; Lee Y.-T.; Tang H.-J.; Lin H.-J.; Liu H.-C.; Lee J.-C.; Tsai B.-Y.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:10Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean S.-S.;Lu M.-C.;Shi Z.-Y.;Tseng S.-H.;Wu T.-S.;Lu P.-L.;Shao P.-L.;Ko W.-C.;Wang F.-D.;Po-Ren Hsueh; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:09Z |
Methicillin-resistant Staphylococcus aureus sequence type 45 with high rates of ciprofloxacin and tetracycline resistance in the residents and environments of long-term care facilities in Taiwan
|
Tseng S.-H.; Lee C.-M.; Chiang H.-T.; Lu M.-C.; Wang L.-F.; Tsai T.-L.; Kang M.-Y.; Jan Y.-N.; Lo Y.-T.; Ko W.-C.; Lai C.-C.; Lai C.-C.;Lee C.-M.;Chiang H.-T.;Lu M.-C.;Wang L.-F.;Tsai T.-L.;Kang M.-Y.;Jan Y.-N.;Lo Y.-T.;Ko W.-C.;Tseng S.-H.;Po-Ren Hsueh; PO-REN HSUEH |
| 臺大學術典藏 |
2020-12-18T08:37:08Z |
Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008))
|
Wu J.-J.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Lee W.-S.; Jean S.-S.; Jean S.-S.;Lee W.-S.;Yu K.-W.;Liao C.-H.;Hsu C.-W.;Chang F.-Y.;Ko W.-C.;Chen R.-J.;Wu J.-J.;Chen Y.-H.;Chen Y.-S.;Liu J.-W.;Lu M.-C.;Lam C.;Liu C.-Y.;Po-Ren Hsueh; PO-REN HSUEH; Chen Y.-H.; Chen Y.-S.; Liu J.-W.; Lu M.-C.; Lam C.; Liu C.-Y. |
| 臺大學術典藏 |
2020-12-18T08:37:07Z |
QuantiFERON-TB gold plus is a more sensitive screening tool than QuantiFERON-TB gold in-tube for latent tuberculosis infection among older adults in long-term care facilities
|
PO-REN HSUEH; Chen Y.-H.; Yu C.-J.; Ko W.-C.; Chien J.-Y.;Chiang H.-T.;Lu M.-C.;Ko W.-C.;Yu C.-J.;Chen Y.-H.;Po-Ren Hsueh; Chien J.-Y.; Chiang H.-T.; Lu M.-C. |
